BRIEF-Genprex Provides Update On Diabetes Gene Therapy Program

Reuters
18 Feb
BRIEF-Genprex Provides Update On Diabetes Gene Therapy Program

Feb 18 (Reuters) - Genprex Inc GNPX.O:

  • GENPREX PROVIDES UPDATE ON DIABETES GENE THERAPY PROGRAM

  • GENPREX INC - SIGNS NEW EXCLUSIVE LICENSE AGREEMENT WITH UNIVERSITY OF PITTSBURGH OF COMMONWEALTH SYSTEM OF HIGHER EDUCATION

  • GENPREX INC - FORMS WHOLLY-OWNED SUBSIDIARY, CONVERGEN BIOTECH

  • GENPREX INC - TO SEEK FDA GUIDANCE FOR IND APPLICATION IN 2025

Source text: ID:nPn7z8NYNa

Further company coverage: GNPX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10